Angiodynamics Inc (ANGO)

R&D to Revenue

9.86%

Quarterly · Period ending:

ANGO logo

ANGO R&D to Revenue

Latest reported9.86%
ANGO Quarterly R&D/Revenue (0.00% → 9.86%)
High-resolution chart · PNG

ANGO r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Angiodynamics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
9.861%
9.4427%
9.0331%
9.7793%
8.4757%
8.2213%
9.6009%
8.8325%
9.3124%
9.4731%
10.8922%
10.9494%
10.0929%
8.6303%
8.4894%
8.0043%
10.2199%
9.0416%
9.8418%
10.4739%
9.6062%
11.8477%
12.0325%
13.3462%
12.8304%
12.398%
12.0307%
11.091%
9.5273%
7.4766%
8.3506%
8.0467%
8.9782%
7.3078%
7.7006%
7.0433%
7.5412%
7.7042%
6.9519%
6.6417%
7.6154%
7.4297%
6.6465%
6.9245%
7.4095%
8.019%
7.916%
6.5861%
7.6926%
7.1791%
7.988%
7.9026%
8.0271%
7.1507%
7.1018%
8.0614%
8.4814%
9.0518%
8.87%
8.8212%
10.2717%
9.8334%
9.7387%
9.8535%
10.1773%
8.9155%
8.2154%
8.9096%
9.6802%
9.1537%
9.4889%
9.1305%
8.9389%
8.6927%
9.7115%
8.9018%
7.2243%
7.4483%
53.2875%
6.7176%
8.0286%
5.7604%
7.3086%
8.2589%
9.2809%
7.466%
6.6408%
7.7906%
8.6074%
6.7569%
7.4367%
6.5866%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.